Pathology of lymphoma

The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Click here to learn more about the University of Texas MD Anderson Cancer Center.

Pathology is an important component with far-reaching impact in cancer diagnostics and treatment.  There are about forty different types of lymphoma, with unique characteristics and targeted treatment needs. 

The Mehta Family Foundation has funded a research project with MD Anderson in the area of the pathology of lymphoma. This project will work to identify targeted biomarker assessments in diffuse large B-cell lymphoma.  The goal is to reveal specific molecular events that play a role in progression and therapeutic response.  Over time, the results of this research will lead to new and better clinical therapies for treating cancer patients.